Minimal expression of the proto-oncogene int-2 encoded protein in a series of colorectal carcinomas

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 10, 2002, Pages 1084-1086

  Papanikolaou, Ioannis S ^a   Lazaris, Andreas C ^a   Kavantzas, Nikolaos ^a   Davaris, Panayiotis S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Colorectal carcinoma; Immunohistochemistry; int 2

Indexed keywords

ANTIBODY; PARAFFIN;

AGED; ARTICLE; CANCER GRADING; CANCER SIZE; CANCER STAGING; COLON CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENDER; GENETIC CODE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUCOSA; ONCOGENE; ONCOGENE INT 2; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTO ONCOGENE; SAMPLING; SHEEP; TISSUE SECTION; TUMOR DIFFERENTIATION;

EID: 0036042797     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02838.x     Document Type: Article

References (10)

1. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line
2. Fibroblast growth factors and their receptors in parathyroid disease
3. Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy
4. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas
5. Gene amplification in gastric and esophageal adenocarcinomas
6. Regulation of FGF-3 gene expression in tumorigenic and non-tumorigenic clones of a human colon carcinoma cell line
7. Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma
8. First hints for a correlation between amplification of the Int-2 gene and infection with human papillomavirus in head and neck squamous cell carcinomas
9. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction
10. Molecular genetics and in vitro sensitivity of a new human cell line, KKP, from a gastric adenocarcinoma